Due to the risk of AAV development, especially in patients with MPO-ANCA, patients with ANCA-ILD require careful, long-term monitoring for systemic vasculitis, including renal function and urinalysis, as up to 50% may develop glomerulonephritis after a median period of 3.2 years [16]. Here, MPO is linked to interstitial lung disease.